Advances and challenges in detection of HER2 low expression in breast cancer.
10.3760/cma.j.cn112151-20220620-00542
- Author:
Yue Ping LIU
1
;
Wei Cheng XUE
2
;
Wen Tao YANG
3
;
Hong BU
4
Author Information
1. Department of Pathology, the Fourth Hospital of Hebei Medical University, Tumor Hospital of Hebei Province, Shijiazhuang 050011, China.
2. Department of Pathology, Peking University Cancer Hospital,Beijing 100142, China.
3. Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
4. Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.
- Publication Type:Journal Article
- MeSH:
Breast Neoplasms/metabolism*;
Female;
Humans;
Receptor, ErbB-2/metabolism*
- From:
Chinese Journal of Pathology
2022;51(9):799-802
- CountryChina
- Language:Chinese
